Back to search
FDAFDA · Food and drugs·Recall number D-1029-2018

Valsartan 320 mg tablets, 90-count bottles ( NDC 71335-0567-2), Rx Only, Packaged by Bryant Ranch, Burbank, CA 91504.

Published August 8, 2018 · Recall initiated: July 27, 2018

Summary

FDA records drug Class II recall D-1029-2018, published August 8, 2018 and initiated July 27, 2018. Recalling firm: Bryant Ranch Prepack Inc.; Status: Terminated; Reported quantity: 90 tablets; Lot: Lot # 120879; Exp 10/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email if VALSARTAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VALSARTAN
Manufacturer
Bryant Ranch Prepack Inc.
Distributor
Product was distributed in HI, IN, and FL.
Lot
Lot # 120879; Exp 10/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan 320 mg tablets, 90-count bottles ( NDC 71335-0567-2), Rx Only, Packaged by Bryant Ranch, Burbank, CA 91504. recalled?

Yes. FDA published recall D-1029-2018 on August 8, 2018. Reported hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VALSARTAN.